The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) has submitted a grant to the National Institutes of Health (NIH) that will aid in further research and commercialization. This grant is being submitted in ...

Background Increasing intentions to quit e-cigarettes among youth and young adults can reduce usage rates by making quit attempts more likely. This study assessed the potential impacts of a national ...

Achieve Life Sciences, Inc., a late-stage pharmaceutical company focused on the global development and commercialization of ...

TAMPA, FL / ACCESS Newswire / / CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) and Johns Hopkins University have successfully submitted our proposal for a NIH Grant that will ...

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, ...

ACHV READ THE FULL ACHV RESEARCH REPORT Update for 2025 Achieve Life Sciences, Inc. (NASDAQ:ACHV) has been busy since its ...

Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US.

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.

This approval also does not mean that these pouches are FDA-approved smoking cessation aids. For health care providers working in primary care, the first-line treatment to recommend to patients ...

AstraZeneca and Daiichi's first co-developed ADC, Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions. In December ...

Future data on overall survival will be beneficial for prescribing the treatment to patients after the approval. 1. FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer.